Stroke specialists play a critical role in managing cerebrovascular events that disrupt brain function and pose life-threatening risks. They are involved in the acute treatment of strokes, employing advanced techniques such as thrombolysis and thrombectomy to restore blood flow and minimize damage to brain tissue. These specialists are at the heart of emergency care, working with stroke units to ensure timely interventions and optimal outcomes. Beyond immediate care, stroke specialists focus on secondary prevention, addressing risk factors such as hypertension, diabetes, and atherosclerosis to reduce the likelihood of future strokes. In addition to their clinical expertise, stroke specialists oversee rehabilitation efforts, guiding patients through recovery from motor impairments, speech difficulties, and cognitive challenges. They integrate various therapies to promote neuroplasticity and functional recovery. Collaboration with other experts, such as neuroradiologists and rehabilitation therapists, ensures a holistic approach to stroke care. Ongoing research by stroke specialists explores innovative treatments, neuroprotective agents, and methods for improving long-term recovery, with a commitment to enhancing quality of life for survivors. As the global incidence of stroke rises, these specialists remain indispensable in improving patient outcomes and advancing stroke care across diverse populations.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom